← 返回

间充质干细胞体外抑制慢性髓系白血病细胞并与氧化应激相关

英文原题:Mesenchymal stem cells inhibited chronic myeloid leukemia cells in vitro, correlating with oxidative stress.

查看英文原题

Mesenchymal stem cells inhibited chronic myeloid leukemia cells in vitro, correlating with oxidative stress.

PubMed 2026/04/23(内容时间) World J Surg Oncol Q1 · IF 2.8(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

MSC 条件培养基抑制 K562 细胞生长,同时伴随氧化应激增加和炎症反应改变。

研究思路结论见上方概要

慢性髓性白血病(CML)起源于骨髓,其进展为急变期是导致患者预后不良的主要原因。研究其潜在机制可能有助于提高患者生存率。

采用光学显微镜和CCK-8实验观察和评估经或未经间充质干细胞(MSC)条件培养基处理的K562细胞(来源于CML的人细胞)的活力。采用流式细胞术评估细胞凋亡和细胞周期变化。使用2,7-二氯荧光素二乙酸酯探针评估细胞内活性氧(ROS)。使用相关检测试剂盒测定抗氧化酶(总超氧化物歧化酶[T-SOD]、过氧化氢酶[CAT]、谷胱甘肽过氧化物酶[GSH-Px])以及丙二醛(MDA),后者是脂质过氧化和氧化应激的标志物。采用Western blotting评估炎症相关蛋白(核因子E2相关因子2[Nrf2]、核因子kappa B alpha抑制因子[I B]),并采用逆转录定量聚合酶链反应(RT-qPCR)评估炎症细胞因子(白细胞介素[IL]-6、IL-1、IL-4、IL-10)的表达。所有实验均重复三次,数据以均值形式表示。采用Welch t检验比较处理组和对照组。

与未经MSC条件培养基处理的K562细胞相比,经MSC条件培养基培养的K562细胞增殖显著受到抑制。与未处理的细胞相比,经MSC条件培养基处理的K562细胞凋亡增加(11.34% vs. 2.93%,P<0.0001),并出现细胞周期阻滞(17.54% vs. 11.00%,P = 0.0007)。此外,经MSC条件培养基处理的K562细胞组细胞内ROS水平升高(9.34% vs. 2.43%,P = 0.0002)。氧化应激因子分析显示,经MSC条件培养基处理的K562细胞组中T-SOD(3.82 vs. 6.89,P = 0.0023)、CAT(21.43 vs. 34.36,P = 0.0025)和GSH-Px(3.42 vs. 6.88,P = 0.0088)水平降低,同时MDA(6.29 vs. 3.30,P = 0.0009)升高。炎症蛋白评估表明,经MSC条件培养基处理的K562细胞组中Nrf2(0.46 vs. 1.00,P = 0.0017)和I B(0.71 vs. 1.00,P = 0.0002)水平降低。IL-6(2.14 vs. 1.00,P<0.0001)和IL-1(2.21 vs. 1.00,P<0.0001)上调,而IL-4(0.52 vs. 1.00,P<0.0001)和IL-10(0.39 vs. 1.00,P<0.0001)下调。

展开英文摘要原文

Chronic myeloid leukemia (CML) originates from bone marrow, and its progression to blast crisis phase is a primary cause of poor prognosis in patients. Investigating its underlying mechanisms may help improve patient survival.

Optical microscopy and Cell Counting Kit-8 assays were utilized to observe and assess the viability of K562 cells (human cells derived from CML) treated with or without mesenchymal stem cell (MSC)-conditioned medium. Flow cytometry was employed to assess apoptosis and cell cycle changes. Intracellular reactive oxygen species (ROS) were assessed utilizing a 2 ,7 -dichlorofluorescin diacetate probe. Antioxidant enzymes (total superoxide dismutase [T-SOD], catalase [CAT], glutathione peroxidase [GSH-Px]) and malondialdehyde (MDA), a marker of lipid peroxidation and oxidative stress, were measured using relevant assay kits. Western blotting was performed to evaluate inflammation-related proteins (nuclear factor erythroid 2-related factor 2 [Nrf2], inhibitor of nuclear factor kappa B alpha [I B ]), and reverse transcription quantitative polymerase chain reaction (RT-qPCR) was utilized to assess expression of inflammatory cytokines (interleukin [IL]-6, IL-1 , IL-4, IL-10). All experiments were repeated three times, and the data were presented in mean form. Welch t-test was used to compare the treatment group and the control group.

Compared with K562 cells without MSC-conditioned medium treatment, those cultured with MSC-conditioned medium exhibited significantly inhibited proliferation. The K562 cells treated with MSC-conditioned medium showed increased apoptosis compared with untreated cells (11.34% vs. 2.93%, P<0.0001) and cell cycle arrest (17.54% vs. 11.00%, P = 0.0007). Additionally, the K562 cell group with MSC-conditioned medium treatment elevated intracellular ROS levels (9.34% vs. 2.43%, P = 0.0002) in K562 cells. Oxidative stress factor analysis revealed decreased T-SOD (3.82 vs. 6.89, P = 0.0023), CAT (21.43 vs. 34.36, P = 0.0025), and GSH-Px (3.42 vs. 6.88, P = 0.0088) levels alongside increased MDA (6.29 vs. 3.30, P = 0.0009) in K562 cell group with MSC-conditioned medium treatment. Inflammatory protein assessment demonstrated reduced Nrf2 (0.46 vs. 1.00, P = 0.0017) and I B (0.71 vs. 1.00, P = 0.0002) levels in the K562 cell group with MSC-conditioned medium treatment. IL-6 (2.14 vs. 1.00, P<0.0001) and IL-1 (2.21 vs. 1.00, P<0.0001) were upregulated, whereas IL-4 (0.52 vs. 1.00, P<0.0001) and IL-10 (0.39 vs. 1.00, P<0.0001) were downregulated.

MSC-conditioned medium inhibited K562 cell growth concomitant with increased oxidative stress and altered inflammatory responses.

论文信息

作者
Zheng Y、Shi C、Chen Y、Lai B、Wu H、Sheng L、Ge Q、Ouyang G
第一作者单位
Department of Haematology, The First Affiliated Hospital of Ningbo University, Ningbo City, Zhejiang Province, China.China
通讯作者单位
Department of Haematology, The First Affiliated Hospital of Ningbo University, Ningbo City, Zhejiang Province, China. yanxiao.nb@outlook.com.China
期刊
World journal of surgical oncology2026 Apr 23
原文标识
PubMed 42026586 · DOI 10.1186/s12957-026-04348-w